Statin drugs and the risk of fracture

JAMA. 2000 Oct 18;284(15):1921; author reply 1922.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Proteins
  • Cholestyramine Resin / pharmacology
  • Fractures, Bone / epidemiology*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
  • Hypolipidemic Agents / pharmacology*
  • Pravastatin / pharmacology*
  • Risk
  • Transforming Growth Factor beta*

Substances

  • BMP2 protein, human
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Proteins
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
  • Transforming Growth Factor beta
  • Cholestyramine Resin
  • Pravastatin